News
Select Year:
Select Category:
Proprietary safety features support advanced therapies across a wide range of patients and ease the burden on caregivers...
Proprietary technology designed to accommodate higher-acuity patients and deliver exceptional performance...
Trading of Agiliti common stock has been suspended on the New York Stock Exchange...
Agiliti Inc. (NYSE: AGTI) (“Agiliti”), today announced its financial results for the fourth quarter and year ended December 31, 2023...
Agiliti Inc. announced that it has entered into a definitive merger agreement...
Agiliti Inc. (NYSE: AGTI) (“Agiliti”), today announced its financial results for the third quarter ended September 30, 2023...
The Agiliti Board of Directors has re-appointed Tom Leonard as Chief Executive Officer...
Agiliti Inc. board of directors approved a share repurchase program that grants the Company authority to repurchase up to $50 million of shares of the...
Agiliti Inc. (NYSE: AGTI) (“Agiliti”), today announced its financial results for the second quarter ended June 30, 2023...